Kubo, Makoto <br/><br/>
LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation.  [electronic resource] 

 -  Journal of neuroimmunology  Dec 2010 
 - 123-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8421 
<br/><br/><label>Standard No.: </label>10.1016/j.jneuroim.2010.07.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>B-Lymphocyte Subsets--drug effects<br/>Down-Regulation--drug effects<br/>Female<br/>Flow Cytometry--methods<br/>Ionomycin--pharmacology<br/>Ionophores--pharmacology<br/>Leucine-Rich Repeat Serine-Threonine Protein Kinase-2<br/>Lipopolysaccharides--pharmacology<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Protein Serine-Threonine Kinases--deficiency<br/>RNA, Messenger--metabolism<br/>Tetradecanoylphorbol Acetate--analogs & derivatives<br/>NF-kappaB-Inducing Kinase